Generex Biotechnology Corporation Achieves Compliance With Nasdaq Capital Market Continued Listing Requirements

Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that on November 14, 2005 it received written confirmation from the Nasdaq Stock Market that the Company has achieved compliance with the continued listing requirements in accordance with Nasdaq Marketplace Rule 4310(c)(4).